Simulations Plus Gears Up for Q1 Earnings: What's in Store?
Werte in diesem Artikel
Simulations Plus, Inc SLP is slated to release first-quarter fiscal 2025 results on Jan. 7.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. The Zacks Consensus Estimate for fiscal first-quarter revenues is pegged at $18.7 million, which indicates growth of 28.9% from the year-ago quarter’s reported figure.Simulations Plus, Inc. Price and EPS Surprise Simulations Plus, Inc. price-eps-surprise | Simulations Plus, Inc. QuoteThe consensus mark for earnings is pegged at 18 cents per share, indicating increase of 80% from the prior-year levels. The company’s earnings have surpassed the Zacks Consensus Estimate in three of the trailing four quarters, while missing in the remaining quarter, with the average earnings surprise of 17.69%.The company reported adjusted earnings (excluding the impact of acquisition costs) of 6 cents per share, which declined 66.7% year over year in the last reported quarter. The figure, however, beat the Zacks Consensus Estimate of 4 cents per share. Revenues jumped 19% year over year to $18.7 million due to higher software and services revenues in the Clinical Pharmacology & Pharmacometrics (CPP), higher software revenues in the Cheminformatics business units and higher service sales in the Quantitative Systems Pharmacology (QSP) unit.Factors to Note Ahead of SLP’s Q1 Earnings ReleaseSimulations Plus’ performance in the fiscal first quarter is likely to have benefited from solid momentum in the software business unit owing to healthy traction witnessed for GastroPlus, MonolixSuite and ADMet Predictor. SLP has been focused on supplementing its organic growth with strategic acquisitions. In June 2024, SLP made one of the most important acquisitions that of Pro-ficiency, which doubled its total addressable market to $8 billion and expanded market opportunity. In the last reported quarter, the acquisition added $2.3 million to total revenues. SLP also remains focused on expanding cross-selling opportunities to drive top-line growth. Service revenues are likely to have gained from steady growth in QSP and CPP business units. The company also continues to expand its global footprint by increasing presence in Europe, Asia and Latin America. In the last reported quarter, Services’ revenues improved 39% to $8.8 million, while QSP and CPP sales saw an increase of 32% and 28% year over year, respectively.The Zacks Consensus Estimate for Software and Services’ revenues in the fiscal first quarter is pegged at $9.69 million and $8.89 million, respectively. However, relatively soft client funding and budget cycles, especially for biotech and pharmaceutical customers, remain concerning amid a volatile macroeconomic environment. SLP highlighted that first-quarter revenues are the lowest due to the seasonality of revenue streams.What Our Model Says About SLPOur proven model does not conclusively predict an earnings beat for SLP this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat.Simulations Plus has an Earnings ESP of 0.00% and a Zacks Rank #1. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.Stocks to ConsiderHere are some stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this time around.Wells Fargo & Company WFC is set to announce quarterly figures on Jan. 15. WFC currently has an Earnings ESP of +4.23% and a Zacks Rank of 1. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for WFC’s to-be-reported quarter’s earnings and revenues is pegged at $1.33 per share and $20.52 billion, respectively. Shares of WFC have risen 42.8% in the past year.The Simply Good Foods Company SMPL presently has an Earnings ESP of +5.50% and a Zacks Rank #3. SMPL is slated to release quarterly numbers on Jan. 8. The Zacks Consensus Estimate for SMPL’s to-be-reported quarter’s earnings and revenues is pegged at 46 cents per share and $348.1 million, respectively. Acuity Brands, Inc. AYI currently has an Earnings ESP of +0.16% and a Zacks Rank #3. AYI is scheduled to report quarterly earnings on Jan. 8. The Zacks Consensus Estimate for AYI’s to-be-reported quarter’s earnings and revenues is pegged at $3.88 per share and $951.9 million, respectively. Shares of AYI have surged 47.5% in the past year.Research Chief Names "Single Best Pick to Double"From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Wells Fargo & Company (WFC): Free Stock Analysis Report Simulations Plus, Inc. (SLP): Free Stock Analysis Report Acuity Brands Inc (AYI): Free Stock Analysis Report The Simply Good Foods Company (SMPL): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Simulations Plus
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Simulations Plus
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Simulations Plus IncShs
Analysen zu Simulations Plus IncShs
Keine Analysen gefunden.